| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A CHRNA9 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 1.67e-11 | 465 | 36 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 SCN11A CHRNA9 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 3.16e-10 | 758 | 36 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A CHRNA9 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 5.20e-10 | 627 | 36 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 SCN11A CHRNA9 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 5.50e-10 | 793 | 36 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.05e-10 | 171 | 36 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A CHRNA9 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 9.97e-10 | 664 | 36 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.96e-09 | 37 | 36 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 SCN11A CHRNA9 SLC6A16 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 6.53e-09 | 1180 | 36 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.86e-09 | 38 | 36 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | transporter activity | ANO9 SCN11A CHRNA9 SLC6A16 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 2.01e-08 | 1289 | 36 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 8.99e-08 | 459 | 36 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.29e-07 | 26 | 36 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.39e-07 | 343 | 36 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | channel activity | 2.80e-07 | 525 | 36 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.85e-07 | 526 | 36 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.17e-06 | 12 | 36 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.93e-06 | 14 | 36 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.26e-06 | 52 | 36 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | symporter activity | 6.99e-06 | 150 | 36 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.34e-05 | 81 | 36 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 3.15e-05 | 5 | 36 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 3.15e-05 | 5 | 36 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 3.39e-05 | 35 | 36 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.10e-05 | 119 | 36 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.34e-05 | 129 | 36 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.53e-04 | 151 | 36 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.72e-04 | 11 | 36 | 2 | GO:0004523 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.79e-04 | 296 | 36 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.84e-04 | 14 | 36 | 2 | GO:0003964 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.13e-04 | 334 | 36 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 3.27e-04 | 15 | 36 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.91e-04 | 193 | 36 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.23e-04 | 197 | 36 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.75e-04 | 18 | 36 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 5.88e-04 | 20 | 36 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.49e-04 | 21 | 36 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 7.81e-04 | 23 | 36 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | alcohol binding | 8.17e-04 | 102 | 36 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | cyclase activity | 8.51e-04 | 24 | 36 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 9.24e-04 | 25 | 36 | 2 | GO:0016849 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 9.84e-04 | 430 | 36 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.24e-03 | 29 | 36 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.56e-03 | 477 | 36 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.02e-03 | 37 | 36 | 2 | GO:0016891 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.03e-03 | 140 | 36 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.04e-03 | 301 | 36 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.13e-03 | 38 | 36 | 2 | GO:0034061 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.48e-03 | 41 | 36 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.52e-03 | 151 | 36 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.11e-03 | 46 | 36 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 4.62e-03 | 884 | 36 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | peptidase activity | 6.04e-03 | 654 | 36 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 6.09e-03 | 207 | 36 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 6.18e-03 | 208 | 36 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 7.07e-03 | 70 | 36 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 7.26e-03 | 71 | 36 | 2 | GO:0015179 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 8.92e-03 | 79 | 36 | 2 | GO:0004521 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 9.50e-03 | 1353 | 36 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.54e-02 | 105 | 36 | 2 | GO:0015171 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.56e-02 | 293 | 36 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | ATPase binding | 1.62e-02 | 108 | 36 | 2 | GO:0051117 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO9 SCN11A CHRNA9 SLC6A16 SLC1A2 SLC10A5 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 3.00e-08 | 1374 | 36 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO9 SCN11A CHRNA9 SLC6A16 SLC1A2 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 2.19e-07 | 1115 | 36 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.16e-07 | 275 | 36 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | syncytium formation | 4.53e-07 | 89 | 36 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A CHRNA9 SLC6A16 SLC10A5 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 6.47e-07 | 1000 | 36 | 11 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO9 SCN11A CHRNA9 SLC6A16 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 7.64e-07 | 1017 | 36 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.48e-06 | 208 | 36 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.08e-06 | 121 | 36 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A CHRNA9 SLC6A16 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 2.67e-06 | 922 | 36 | 10 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A CHRNA9 SLC6A16 SLC10A5 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 2.70e-06 | 1157 | 36 | 11 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A CHRNA9 SLC6A16 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A SLC5A3 | 3.23e-06 | 942 | 36 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 4.29e-06 | 559 | 36 | 8 | GO:0042391 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 4.33e-06 | 63 | 36 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.43e-05 | 85 | 36 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.43e-05 | 85 | 36 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | action potential | 2.47e-05 | 201 | 36 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.35e-05 | 36 | 36 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.24e-05 | 112 | 36 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 4.42e-05 | 6 | 36 | 2 | GO:0140009 | |
| GeneOntologyBiologicalProcess | regulation of membrane hyperpolarization | 6.19e-05 | 7 | 36 | 2 | GO:1902630 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.20e-04 | 55 | 36 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.56e-04 | 60 | 36 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 1.61e-04 | 11 | 36 | 2 | GO:0070778 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.72e-04 | 62 | 36 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.98e-04 | 65 | 36 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.28e-04 | 13 | 36 | 2 | GO:0015074 | |
| GeneOntologyBiologicalProcess | circulatory system process | 2.36e-04 | 733 | 36 | 7 | GO:0003013 | |
| GeneOntologyBiologicalProcess | gastro-intestinal system smooth muscle contraction | 3.07e-04 | 15 | 36 | 2 | GO:0014831 | |
| GeneOntologyBiologicalProcess | muscle system process | 3.35e-04 | 547 | 36 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | amino acid transport | 3.60e-04 | 195 | 36 | 4 | GO:0006865 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 4.22e-04 | 84 | 36 | 3 | GO:0051480 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.68e-04 | 87 | 36 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 4.97e-04 | 19 | 36 | 2 | GO:0098712 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 5.12e-04 | 1395 | 36 | 9 | GO:0007186 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 5.61e-04 | 392 | 36 | 5 | GO:0070588 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.69e-04 | 93 | 36 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 6.07e-04 | 224 | 36 | 4 | GO:0007204 | |
| GeneOntologyBiologicalProcess | membrane hyperpolarization | 6.09e-04 | 21 | 36 | 2 | GO:0060081 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.15e-04 | 400 | 36 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 6.69e-04 | 22 | 36 | 2 | GO:0015810 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte chemotaxis | 7.32e-04 | 23 | 36 | 2 | GO:0002689 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 7.32e-04 | 23 | 36 | 2 | GO:0009190 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 8.33e-04 | 106 | 36 | 3 | GO:0015914 | |
| GeneOntologyBiologicalProcess | chronic inflammatory response | 8.66e-04 | 25 | 36 | 2 | GO:0002544 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 9.38e-04 | 26 | 36 | 2 | GO:0017121 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 1.17e-03 | 29 | 36 | 2 | GO:0015740 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 1.17e-03 | 267 | 36 | 4 | GO:0002685 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.31e-03 | 1272 | 36 | 8 | GO:1901698 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 1.33e-03 | 31 | 36 | 2 | GO:0007635 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.40e-03 | 127 | 36 | 3 | GO:0070252 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.43e-03 | 722 | 36 | 6 | GO:0051606 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.60e-03 | 133 | 36 | 3 | GO:0006939 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 1.70e-03 | 35 | 36 | 2 | GO:0015813 | |
| GeneOntologyBiologicalProcess | lipid transport | 1.75e-03 | 506 | 36 | 5 | GO:0006869 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.80e-03 | 509 | 36 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | regulation of macrophage chemotaxis | 1.90e-03 | 37 | 36 | 2 | GO:0010758 | |
| GeneOntologyBiologicalProcess | response to auditory stimulus | 1.90e-03 | 37 | 36 | 2 | GO:0010996 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.93e-03 | 142 | 36 | 3 | GO:0046683 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte chemotaxis | 1.97e-03 | 143 | 36 | 3 | GO:0002688 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 2.02e-03 | 1361 | 36 | 8 | GO:0009628 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 2.19e-03 | 317 | 36 | 4 | GO:0090257 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 2.33e-03 | 41 | 36 | 2 | GO:0035025 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.39e-03 | 153 | 36 | 3 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 2.68e-03 | 44 | 36 | 2 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 2.80e-03 | 45 | 36 | 2 | GO:0009187 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 2.81e-03 | 162 | 36 | 3 | GO:0015748 | |
| GeneOntologyBiologicalProcess | lipid localization | 2.83e-03 | 565 | 36 | 5 | GO:0010876 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 2.92e-03 | 46 | 36 | 2 | GO:0051938 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 3.01e-03 | 166 | 36 | 3 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.06e-03 | 167 | 36 | 3 | GO:0060048 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.18e-03 | 48 | 36 | 2 | GO:0000731 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 3.22e-03 | 582 | 36 | 5 | GO:0050906 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 3.38e-03 | 173 | 36 | 3 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 3.49e-03 | 175 | 36 | 3 | GO:0009582 | |
| GeneOntologyCellularComponent | cation channel complex | 6.60e-09 | 235 | 37 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.50e-08 | 378 | 37 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.39e-07 | 523 | 37 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 3.65e-07 | 550 | 37 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.41e-06 | 17 | 37 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | membrane protein complex | SCN11A CHRNA9 SLC1A2 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 STT3B SCN4A SLC5A3 | 6.02e-06 | 1498 | 37 | 12 | GO:0098796 |
| GeneOntologyCellularComponent | sodium channel complex | 1.81e-05 | 29 | 37 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.21e-04 | 277 | 37 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | 5.11e-04 | 583 | 37 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | presynapse | 8.11e-04 | 886 | 37 | 7 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 8.38e-04 | 891 | 37 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | astrocyte projection | 8.91e-04 | 25 | 37 | 2 | GO:0097449 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.36e-03 | 785 | 37 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.89e-03 | 817 | 37 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | glial cell projection | 3.13e-03 | 47 | 37 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | distal axon | 7.10e-03 | 435 | 37 | 4 | GO:0150034 | |
| GeneOntologyCellularComponent | calcium channel complex | 7.40e-03 | 73 | 37 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | dendritic shaft | 7.60e-03 | 74 | 37 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.03e-03 | 233 | 37 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | neuron projection membrane | 9.26e-03 | 82 | 37 | 2 | GO:0032589 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 3.67e-05 | 27 | 13 | 3 | HP:0031475 | |
| MousePheno | abnormal nervous system electrophysiology | 7.55e-10 | 329 | 22 | 9 | MP:0002272 | |
| MousePheno | abnormal action potential | 1.67e-06 | 133 | 22 | 5 | MP:0005402 | |
| MousePheno | abnormal excitatory postsynaptic currents | 3.24e-05 | 119 | 22 | 4 | MP:0002910 | |
| Domain | Ion_trans_dom | 9.82e-10 | 114 | 33 | 7 | IPR005821 | |
| Domain | Ion_trans | 9.82e-10 | 114 | 33 | 7 | PF00520 | |
| Domain | TRP_dom | 1.00e-07 | 6 | 33 | 3 | IPR013555 | |
| Domain | TRP_2 | 1.00e-07 | 6 | 33 | 3 | PF08344 | |
| Domain | TRPC_channel | 1.75e-07 | 7 | 33 | 3 | IPR002153 | |
| Domain | Na_channel_asu | 5.98e-07 | 10 | 33 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 5.98e-07 | 10 | 33 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 5.98e-07 | 10 | 33 | 3 | PF06512 | |
| Domain | TRP_channel | 8.21e-07 | 11 | 33 | 3 | IPR004729 | |
| Domain | Na-dicarboxylate_symporter | 6.32e-05 | 7 | 33 | 2 | IPR001991 | |
| Domain | SDF | 6.32e-05 | 7 | 33 | 2 | PF00375 | |
| Domain | - | 6.32e-05 | 7 | 33 | 2 | 1.10.3860.10 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 6.32e-05 | 7 | 33 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 6.32e-05 | 7 | 33 | 2 | PS00714 | |
| Domain | Na-dicarboxylate_symporter_CS | 6.32e-05 | 7 | 33 | 2 | IPR018107 | |
| Domain | Channel_four-helix_dom | 1.38e-04 | 57 | 33 | 3 | IPR027359 | |
| Domain | - | 1.38e-04 | 57 | 33 | 3 | 1.20.120.350 | |
| Domain | A/G_cyclase_CS | 4.05e-04 | 17 | 33 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 4.55e-04 | 18 | 33 | 2 | IPR029787 | |
| Domain | - | 4.55e-04 | 18 | 33 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.08e-04 | 19 | 33 | 2 | PS50125 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.08e-04 | 19 | 33 | 2 | PS00452 | |
| Domain | A/G_cyclase | 5.08e-04 | 19 | 33 | 2 | IPR001054 | |
| Domain | CYCc | 5.08e-04 | 19 | 33 | 2 | SM00044 | |
| Domain | Guanylate_cyc | 5.08e-04 | 19 | 33 | 2 | PF00211 | |
| Domain | GPCR_Rhodpsn_7TM | 6.04e-03 | 670 | 33 | 5 | IPR017452 | |
| Domain | 7tm_1 | 6.31e-03 | 677 | 33 | 5 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 6.62e-03 | 685 | 33 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.87e-03 | 691 | 33 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.91e-03 | 692 | 33 | 5 | IPR000276 | |
| Domain | Ank | 7.48e-03 | 228 | 33 | 3 | PF00023 | |
| Domain | IQ | 8.99e-03 | 81 | 33 | 2 | SM00015 | |
| Domain | - | 9.41e-03 | 248 | 33 | 3 | 1.25.40.20 | |
| Domain | ANK | 9.72e-03 | 251 | 33 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 9.93e-03 | 253 | 33 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.00e-02 | 254 | 33 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.00e-02 | 254 | 33 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 1.09e-02 | 262 | 33 | 3 | IPR002110 | |
| Domain | IQ_motif_EF-hand-BS | 1.10e-02 | 90 | 33 | 2 | IPR000048 | |
| Domain | IQ | 1.17e-02 | 93 | 33 | 2 | PS50096 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 1.22e-08 | 15 | 26 | 4 | M22002 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 6.63e-07 | 10 | 26 | 3 | M27330 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.77e-05 | 28 | 26 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.77e-05 | 28 | 26 | 3 | M27241 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.42e-05 | 31 | 26 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.67e-05 | 32 | 26 | 3 | M27455 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.04e-05 | 99 | 26 | 4 | MM14910 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.58e-05 | 736 | 26 | 8 | M27287 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.97e-05 | 106 | 26 | 4 | M27200 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 7.02e-05 | 44 | 26 | 3 | M875 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.75e-04 | 681 | 26 | 7 | MM14985 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.83e-04 | 176 | 26 | 4 | MM15718 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.21e-04 | 335 | 26 | 5 | MM14503 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.29e-04 | 183 | 26 | 4 | M997 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.87e-04 | 203 | 26 | 4 | M5485 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.14e-04 | 575 | 26 | 6 | M29853 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.63e-04 | 211 | 26 | 4 | MM14502 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 8.15e-04 | 411 | 26 | 5 | M735 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 8.74e-04 | 636 | 26 | 6 | M41834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.81e-04 | 24 | 26 | 2 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 8.81e-04 | 24 | 26 | 2 | M630 | |
| Pathway | WP_DRAVET_SYNDROME | 1.20e-03 | 28 | 26 | 2 | M45519 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.39e-03 | 121 | 26 | 3 | M872 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.41e-03 | 270 | 26 | 4 | M15514 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.71e-03 | 130 | 26 | 3 | M27454 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.11e-03 | 140 | 26 | 3 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.95e-03 | 51 | 26 | 2 | MM14499 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.95e-03 | 51 | 26 | 2 | M4281 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 4.57e-03 | 55 | 26 | 2 | M39763 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 5.28e-03 | 389 | 26 | 4 | M14091 | |
| Pubmed | 5.33e-10 | 12 | 37 | 4 | 14557543 | ||
| Pubmed | 6.40e-09 | 21 | 37 | 4 | 30270038 | ||
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 1.11e-08 | 5 | 37 | 3 | 12857742 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 1.11e-08 | 5 | 37 | 3 | 12736151 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 11390792 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 2.21e-08 | 6 | 37 | 3 | 8646775 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 25347706 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 32414784 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 15063128 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 3.87e-08 | 7 | 37 | 3 | 15757897 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 38835669 | ||
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 3.87e-08 | 7 | 37 | 3 | 23233529 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 32350291 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 3.87e-08 | 7 | 37 | 3 | 15336983 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 36257322 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 5.27e-08 | 94 | 37 | 5 | 21542922 | |
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 6.18e-08 | 8 | 37 | 3 | 12032305 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 15199065 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 25471572 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 11290752 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 16382098 | ||
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 9.27e-08 | 9 | 37 | 3 | 14505576 | |
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 17480026 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 1.32e-07 | 10 | 37 | 3 | 18989690 | |
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 27177420 | ||
| Pubmed | 3.15e-07 | 13 | 37 | 3 | 22051675 | ||
| Pubmed | 7.46e-07 | 17 | 37 | 3 | 22411552 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 34899056 | ||
| Pubmed | Differential distribution of TRP Ca2+ channel isoforms in mouse brain. | 1.10e-06 | 2 | 37 | 2 | 9512398 | |
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 1.10e-06 | 2 | 37 | 2 | 17593972 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 16537542 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 22457348 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23677990 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 26317356 | ||
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 1.10e-06 | 2 | 37 | 2 | 32033274 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 9060628 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 17624425 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.10e-06 | 2 | 37 | 2 | 9460924 | |
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 1.10e-06 | 2 | 37 | 2 | 9687496 | |
| Pubmed | TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. | 1.10e-06 | 2 | 37 | 2 | 30038709 | |
| Pubmed | 2.21e-06 | 24 | 37 | 3 | 9722956 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.21e-06 | 24 | 37 | 3 | 33884443 | |
| Pubmed | 2.51e-06 | 25 | 37 | 3 | 16382100 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 32359120 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 28790178 | ||
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 3.30e-06 | 3 | 37 | 2 | 30755645 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 15358862 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 15647288 | ||
| Pubmed | Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels. | 3.30e-06 | 3 | 37 | 2 | 28325835 | |
| Pubmed | Inositol 1,4,5-trisphosphate signaling maintains the activity of glutamate uptake in Bergmann glia. | 3.30e-06 | 3 | 37 | 2 | 20958799 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 10516026 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 9971820 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 34199280 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 28178648 | ||
| Pubmed | Dual action of the Gαq-PLCβ-PI(4,5)P2 pathway on TRPC1/4 and TRPC1/5 heterotetramers. | 3.30e-06 | 3 | 37 | 2 | 30108272 | |
| Pubmed | 5.92e-06 | 33 | 37 | 3 | 19834762 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 18261457 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 9379843 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 20164195 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 12356946 | ||
| Pubmed | NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. | 6.60e-06 | 4 | 37 | 2 | 22539836 | |
| Pubmed | The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing. | 6.60e-06 | 4 | 37 | 2 | 26520460 | |
| Pubmed | Phospholipase cgamma1 is required for activation of store-operated channels in human keratinocytes. | 6.60e-06 | 4 | 37 | 2 | 15654973 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 7983737 | ||
| Pubmed | Impact of Reduced Cerebellar EAAT Expression on Purkinje Cell Firing Pattern of NPC1-deficient Mice. | 6.60e-06 | 4 | 37 | 2 | 29463856 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 23188715 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 28636132 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 32110987 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.11e-06 | 38 | 37 | 3 | 30786075 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 15611229 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.10e-05 | 5 | 37 | 2 | 12629516 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 9129177 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 30452936 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 10980202 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 20458742 | ||
| Pubmed | TRPC3 channels are required for synaptic transmission and motor coordination. | 1.10e-05 | 5 | 37 | 2 | 18701065 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 17724025 | ||
| Pubmed | 1.42e-05 | 44 | 37 | 3 | 19322198 | ||
| Pubmed | TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses. | 1.65e-05 | 6 | 37 | 2 | 31536487 | |
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.65e-05 | 6 | 37 | 2 | 17513486 | |
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 29373286 | ||
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 36476978 | ||
| Pubmed | 3.95e-05 | 9 | 37 | 2 | 15746173 | ||
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 12970426 | ||
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 21147989 | ||
| Pubmed | 1.67e-04 | 18 | 37 | 2 | 18664271 | ||
| Pubmed | SHARPIN negatively associates with TRAF2-mediated NFκB activation. | 1.86e-04 | 19 | 37 | 2 | 21829440 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 2.72e-04 | 118 | 37 | 3 | 19156168 | |
| Pubmed | 2.75e-04 | 23 | 37 | 2 | 16446141 | ||
| Pubmed | 3.80e-04 | 27 | 37 | 2 | 16460286 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 4.39e-04 | 139 | 37 | 3 | 16985003 | |
| Pubmed | 6.41e-04 | 35 | 37 | 2 | 18498732 | ||
| Pubmed | Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. | 7.16e-04 | 37 | 37 | 2 | 18498735 | |
| Pubmed | 7.56e-04 | 38 | 37 | 2 | 10834841 | ||
| Interaction | TRPC4 interactions | 5.17e-06 | 23 | 30 | 3 | int:TRPC4 | |
| Interaction | TRPC5 interactions | 5.90e-06 | 24 | 30 | 3 | int:TRPC5 | |
| Interaction | TRPC6 interactions | 6.44e-06 | 82 | 30 | 4 | int:TRPC6 | |
| Interaction | TRPC1 interactions | 1.06e-05 | 29 | 30 | 3 | int:TRPC1 | |
| Interaction | TRPC3 interactions | 1.58e-05 | 33 | 30 | 3 | int:TRPC3 | |
| Interaction | ITPR1 interactions | 5.46e-05 | 141 | 30 | 4 | int:ITPR1 | |
| Interaction | MX1 interactions | 9.62e-05 | 60 | 30 | 3 | int:MX1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.44e-07 | 9 | 30 | 3 | 1203 | |
| GeneFamily | Transient receptor potential cation channels | 1.31e-05 | 28 | 30 | 3 | 249 | |
| GeneFamily | Solute carriers | 4.41e-04 | 395 | 30 | 5 | 752 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.73e-05 | 63 | 28 | 3 | gudmap_kidney_adult_RenMedVasc_Tie2_k1_1000 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 1.15e-04 | 72 | 28 | 3 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 1.20e-04 | 73 | 28 | 3 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | BM Top 100 - parietal lobe | 1.30e-04 | 75 | 28 | 3 | BM Top 100 - parietal lobe | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.34e-06 | 181 | 32 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 9.09e-06 | 185 | 32 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-06 | 188 | 32 | 4 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 190 | 32 | 4 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 196 | 32 | 4 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 131 | 32 | 3 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 146 | 32 | 3 | 281144e293e8c93a425c2606d2188cb2838e667f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 154 | 32 | 3 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 154 | 32 | 3 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 155 | 32 | 3 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 157 | 32 | 3 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 162 | 32 | 3 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 162 | 32 | 3 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 162 | 32 | 3 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-04 | 163 | 32 | 3 | edca1d1a345109dbdeb7ee5464faefab1993fdb2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 32 | 3 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 32 | 3 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 32 | 3 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-04 | 170 | 32 | 3 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.43e-04 | 170 | 32 | 3 | d6e244725b21592c6056b9c443aac090f1eae836 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.47e-04 | 171 | 32 | 3 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 172 | 32 | 3 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.55e-04 | 173 | 32 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 175 | 32 | 3 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 175 | 32 | 3 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 177 | 32 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 177 | 32 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 177 | 32 | 3 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-04 | 179 | 32 | 3 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 179 | 32 | 3 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | 3d54cc767e25d91ed2203d8a03e5bf5e15f21699 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-04 | 181 | 32 | 3 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.01e-04 | 183 | 32 | 3 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.06e-04 | 184 | 32 | 3 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 184 | 32 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 32 | 3 | e592c27f711d13bfc6546893acaab4c8600b0be1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 185 | 32 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 185 | 32 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 185 | 32 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 185 | 32 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.21e-04 | 187 | 32 | 3 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 187 | 32 | 3 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 187 | 32 | 3 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.26e-04 | 188 | 32 | 3 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.26e-04 | 188 | 32 | 3 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.36e-04 | 190 | 32 | 3 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-04 | 190 | 32 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-04 | 190 | 32 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.41e-04 | 191 | 32 | 3 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-04 | 191 | 32 | 3 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-04 | 191 | 32 | 3 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-04 | 192 | 32 | 3 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.57e-04 | 194 | 32 | 3 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-04 | 194 | 32 | 3 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-04 | 194 | 32 | 3 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-04 | 194 | 32 | 3 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 195 | 32 | 3 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 196 | 32 | 3 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-04 | 196 | 32 | 3 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 196 | 32 | 3 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.68e-04 | 196 | 32 | 3 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| Drug | sodium | ERVK-6 CHRNA9 SLC6A16 SLC1A2 ADCY3 SLC1A6 HCN1 TRPC3 SCN2A TRPC4 TRPC5 SCN4A | 2.52e-09 | 944 | 32 | 12 | CID000000923 |
| Drug | sipatrigine | 2.05e-07 | 37 | 32 | 4 | CID000060803 | |
| Drug | 1-oleoyl-2-acetylglycerol | 1.13e-06 | 15 | 32 | 3 | ctd:C038237 | |
| Drug | Zonisamide | 1.69e-06 | 17 | 32 | 3 | DB00909 | |
| Drug | methylglucamine | 1.69e-06 | 62 | 32 | 4 | CID000004049 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.91e-06 | 2 | 32 | 2 | ctd:C502265 | |
| Drug | glutamate | 4.82e-06 | 962 | 32 | 9 | CID000000611 | |
| Drug | Fospropofol | 1.15e-05 | 4 | 32 | 2 | DB06716 | |
| Drug | Propofol | 1.15e-05 | 4 | 32 | 2 | DB00818 | |
| Drug | pseudococaine | 1.16e-05 | 570 | 32 | 7 | CID000002826 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 1.90e-05 | 37 | 32 | 3 | CID000009643 | |
| Drug | 5-bromotryptophan | 1.91e-05 | 5 | 32 | 2 | CID000096735 | |
| Drug | APETx1, Anthopleura elegantissima | 2.86e-05 | 6 | 32 | 2 | ctd:C475726 | |
| Drug | $l^{1}-borane | 3.21e-05 | 44 | 32 | 3 | CID006397184 | |
| Drug | lanthanum | 3.85e-05 | 136 | 32 | 4 | CID000023926 | |
| Drug | beta-hydroxyaspartic acid | 3.92e-05 | 47 | 32 | 3 | CID000005425 | |
| Drug | fluorocyclobutane | 4.00e-05 | 7 | 32 | 2 | CID011051569 | |
| Drug | potassium | 5.84e-05 | 1008 | 32 | 8 | CID000000813 | |
| Drug | chloride | 6.76e-05 | 1029 | 32 | 8 | CID000000312 | |
| Drug | calmidazolium chloride | 7.24e-05 | 160 | 32 | 4 | CID000002531 | |
| Drug | NSC59257 | 7.38e-05 | 58 | 32 | 3 | CID000001094 | |
| Drug | AC1L1BDQ | 9.80e-05 | 173 | 32 | 4 | CID000001394 | |
| Drug | Methoxychlor | 1.02e-04 | 549 | 32 | 6 | ctd:D008731 | |
| Drug | serotonin | 1.07e-04 | 554 | 32 | 6 | CID000005202 | |
| Drug | NSC7524 | 1.19e-04 | 182 | 32 | 4 | CID000005657 | |
| Drug | L-Carnosine | 1.47e-04 | 73 | 32 | 3 | CID000009369 | |
| Drug | anthglutin | 1.48e-04 | 13 | 32 | 2 | CID000125748 | |
| Drug | 20(S)-Propanaxidiol | 1.48e-04 | 13 | 32 | 2 | CID005317623 | |
| Drug | Chlorine | 1.49e-04 | 367 | 32 | 5 | ctd:D002713 | |
| Drug | AC1L1E5T | 1.53e-04 | 74 | 32 | 3 | CID000002653 | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; HL60; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3053_DN | |
| Drug | hemicholinium-3 | 1.79e-04 | 78 | 32 | 3 | CID000003585 | |
| Drug | DL-Serine | 1.81e-04 | 203 | 32 | 4 | CID000000617 | |
| Drug | nonanol | 1.99e-04 | 15 | 32 | 2 | CID000008914 | |
| Drug | apholate | 1.99e-04 | 15 | 32 | 2 | CID000005845 | |
| Drug | bumetanide | 2.03e-04 | 209 | 32 | 4 | CID000002471 | |
| Drug | malonate | 2.03e-04 | 209 | 32 | 4 | CID000000867 | |
| Drug | tetracaine | 2.55e-04 | 88 | 32 | 3 | CID000005411 | |
| Drug | S-1360 | 2.57e-04 | 17 | 32 | 2 | CID006451047 | |
| Drug | DB08666 | 2.73e-04 | 90 | 32 | 3 | CID011840988 | |
| Drug | Scorpion Venoms | 2.89e-04 | 18 | 32 | 2 | ctd:D012604 | |
| Drug | adenosine diphosphoribose | 2.91e-04 | 92 | 32 | 3 | CID000030243 | |
| Drug | tetradotoxin | 3.04e-04 | 428 | 32 | 5 | CID000020382 | |
| Drug | Chlorpyrifos | 3.09e-04 | 960 | 32 | 7 | ctd:D004390 | |
| Drug | 4-azidobenzoic acid | 3.22e-04 | 19 | 32 | 2 | CID003034184 | |
| Drug | carbachol | 3.45e-04 | 688 | 32 | 6 | CID000002551 | |
| Drug | U1-1 | 3.50e-04 | 98 | 32 | 3 | CID006914645 | |
| Drug | Gadolinium | 3.95e-04 | 21 | 32 | 2 | ctd:D005682 | |
| Drug | reproterol | 3.95e-04 | 21 | 32 | 2 | CID000025654 | |
| Drug | 1bkm | 3.95e-04 | 21 | 32 | 2 | CID000444589 | |
| Drug | methanethiosulfonate | 4.05e-04 | 103 | 32 | 3 | CID004188587 | |
| Drug | AC1NPPZW | 4.05e-04 | 103 | 32 | 3 | CID005183170 | |
| Drug | DL-valine | 4.29e-04 | 105 | 32 | 3 | CID000001182 | |
| Drug | 3-iodo-4-hydroxybenzoic acid | 4.34e-04 | 22 | 32 | 2 | CID000449473 | |
| Drug | bosentan | 4.41e-04 | 106 | 32 | 3 | CID000104865 | |
| Drug | NAIN | 5.18e-04 | 24 | 32 | 2 | CID000195228 | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 5.18e-04 | 24 | 32 | 2 | CID000079091 | |
| Drug | 3-Nitrobenzaldoxime | 5.45e-04 | 114 | 32 | 3 | CID000219132 | |
| Drug | lamotrigine | 5.63e-04 | 25 | 32 | 2 | ctd:C047781 | |
| Drug | anabasine | 5.63e-04 | 25 | 32 | 2 | CID000002181 | |
| Drug | Multicide | 5.63e-04 | 25 | 32 | 2 | CID000024365 | |
| Drug | 7B-forskolin | 6.09e-04 | 26 | 32 | 2 | CID000130638 | |
| Drug | Clorocruoro Hem | 6.81e-04 | 123 | 32 | 3 | CID003518809 | |
| Drug | niflumic acid | 7.13e-04 | 125 | 32 | 3 | CID000004488 | |
| Drug | 2-aminoethyl diphenylborinate | 7.47e-04 | 127 | 32 | 3 | CID000001598 | |
| Drug | 1,2-dioxane | 7.59e-04 | 29 | 32 | 2 | CID000138570 | |
| Drug | Linuron | 7.64e-04 | 128 | 32 | 3 | ctd:D008044 | |
| Drug | enzacamene | 7.82e-04 | 129 | 32 | 3 | ctd:C038939 | |
| Drug | myo-inositol | 8.22e-04 | 811 | 32 | 6 | CID000000892 | |
| Drug | His-pro-dkp | 8.68e-04 | 31 | 32 | 2 | CID000065137 | |
| Drug | AC1L1KC5 | 8.81e-04 | 541 | 32 | 5 | CID000005428 | |
| Drug | octylmethoxycinnamate | 9.70e-04 | 139 | 32 | 3 | ctd:C118580 | |
| Drug | dodecanethiol | 9.83e-04 | 33 | 32 | 2 | CID000008195 | |
| Drug | dibutyryl cyclic 3',5'-AMP | 1.04e-03 | 561 | 32 | 5 | CID000002460 | |
| Drug | BAPTA | 1.06e-03 | 324 | 32 | 4 | CID000104751 | |
| Drug | tacrine | 1.07e-03 | 144 | 32 | 3 | CID000001935 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 1.09e-03 | 568 | 32 | 5 | CID000000806 | |
| Drug | ethyldichloroarsine | 1.11e-03 | 35 | 32 | 2 | CID000011711 | |
| Drug | 11-R | 1.11e-03 | 35 | 32 | 2 | CID016058680 | |
| Drug | salbutamol | 1.12e-03 | 146 | 32 | 3 | CID000002083 | |
| Drug | azetidine | 1.17e-03 | 36 | 32 | 2 | CID000010422 | |
| Drug | benzocaine | 1.24e-03 | 37 | 32 | 2 | CID000002337 | |
| Drug | N,N-diethylbenzamide | 1.30e-03 | 38 | 32 | 2 | CID000015542 | |
| Drug | 2g6p | 1.30e-03 | 38 | 32 | 2 | CID002740174 | |
| Drug | N-bromoacetamide | 1.30e-03 | 38 | 32 | 2 | CID000004353 | |
| Drug | procymidone | 1.33e-03 | 155 | 32 | 3 | ctd:C035988 | |
| Drug | AC1L1EST | 1.37e-03 | 39 | 32 | 2 | CID000002932 | |
| Drug | butylparaben | 1.38e-03 | 157 | 32 | 3 | ctd:C038091 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.25e-07 | 10 | 31 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.25e-07 | 10 | 31 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.30e-07 | 12 | 31 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.30e-07 | 12 | 31 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 9.04e-06 | 477 | 31 | 6 | C0005586 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.59e-05 | 145 | 31 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.51e-05 | 163 | 31 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.83e-05 | 9 | 31 | 2 | C3502809 | |
| Disease | Manic Disorder | 5.72e-05 | 71 | 31 | 3 | C0024713 | |
| Disease | Manic | 7.57e-05 | 78 | 31 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 7.87e-05 | 79 | 31 | 3 | C0005587 | |
| Disease | Epilepsy, Cryptogenic | 8.79e-05 | 82 | 31 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 8.79e-05 | 82 | 31 | 3 | C0751111 | |
| Disease | Aura | 8.79e-05 | 82 | 31 | 3 | C0236018 | |
| Disease | Epilepsy | 2.04e-04 | 109 | 31 | 3 | C0014544 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.44e-04 | 22 | 31 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Global developmental delay | 3.67e-04 | 133 | 31 | 3 | C0557874 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.42e-04 | 152 | 31 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 1.03e-03 | 190 | 31 | 3 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EELMQMLIQMKLSLV | 1006 | Q14146 | |
| MLLAALMIVSMVVSL | 76 | O71037 | |
| MLLAALMIVSMVVSL | 76 | Q902F8 | |
| MLLAALMIVSMVVSL | 76 | Q9UKH3 | |
| MMNVALVDLIFIMTL | 61 | Q14330 | |
| LLAMTVFQLMVAEIM | 276 | Q9UGM1 | |
| TVILVLTLLMICLMI | 331 | A1A5B4 | |
| SMLIRNVAVMLPVML | 161 | Q8NH61 | |
| MVILLAVVTLMVTLV | 196 | Q8NGE1 | |
| DLIMLIMMVGNLVII | 146 | O60741 | |
| YIAMVMMKAILVTLL | 441 | P11511 | |
| MLLAALMIVSMVVSL | 76 | P61570 | |
| MLLAALMIVSMVVSL | 76 | Q69384 | |
| NILNEIVMKLVIMIM | 271 | P43004 | |
| MAMLATMVVQILRLR | 586 | Q9Y653 | |
| IMLVQVSHMVKLTLM | 766 | O60266 | |
| LMRMLQMLVLPLIVS | 96 | P48664 | |
| RILIALMSLSMGIIM | 51 | Q96PG1 | |
| MLLAALMIVSMVVSL | 76 | Q902F9 | |
| SSLLLLLPLMLMSMV | 6 | Q6UXB2 | |
| VLLIIFVTMMVHLCM | 621 | Q9GZN6 | |
| DITIMILICLNMVTM | 1356 | P35499 | |
| MVNLTMADMLFLITL | 56 | P25105 | |
| MLLSIGMLMLSATQV | 1 | O43567 | |
| LMIIGALTLMIISIM | 191 | P53794 | |
| LLTIMENLMLLLMIR | 36 | Q8NH09 | |
| ILMTCTSTLLALIMM | 236 | Q5PT55 | |
| LLTMLAMLLKVAMNR | 556 | Q9Y5Q9 | |
| VMVRLMLTLTPVVCM | 456 | Q8TCJ2 | |
| LIGQILMEVLMMSTQ | 201 | O95155 | |
| TVFMMVMVIGNLVVL | 961 | Q99250 | |
| IIISLIILNMISMMA | 1371 | Q9UI33 | |
| ISLVVLLNMLIAMMN | 611 | Q9UL62 | |
| LLMLKQQITMEMSAL | 1091 | Q9H2Y7 | |
| SAIMILTMLLMLKLC | 81 | Q8N2U9 | |
| VISLVVLLNMLIAMM | 606 | Q9UBN4 | |
| MVVVLLNMLIAMINS | 646 | Q13507 | |
| AVQIALMALKMMELS | 546 | Q02108 |